Aignostics and Proscia partner to bring next-generation spatial profiling to Concentriq

Understanding the tumor microenvironment (TME) is central to oncology drug development, but quantifying it at scale remains a challenge for pathologists. Atlas H&E-TME, Aignostics' AI-powered application for spatial analysis of H&E images, provides cell and tissue overlays plus thousands of quantitative features spanning individual cells, tissue regions, and spatial neighborhoods.

Now, we're excited to announce that Atlas H&E-TME is available in Concentriq, Proscia's industry-leading enterprise pathology platform.

Whyit matters:

🔄 Fits into your existing workflow: run Atlas H&E-TME in Concentriq.    

⏱️ Make fast decisions: quantitative TME results are available alongside your other data to give you a complete picture.

🛡️ A stepping stone to clinical trials: opens a clear path to governed, audit-ready, pipelines for clinical trials.      

Want to see it in action?

👉 Request a demo from Aignostics: https://www.aignostics.com/products/atlas-he-tme/for-life-sciences, OR

📩 Connect with Proscia to learn more: https://proscia.com/contact#connect